Ironwood Pharmaceuticals
IRWD
#6792
Rank
S$0.81 B
Marketcap
S$5.01
Share price
-14.10%
Change (1 day)
106.27%
Change (1 year)

Earnings for Ironwood Pharmaceuticals (IRWD)

Earnings in 2025 (TTM): S$0.11 Billion

According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are S$0.33 Billion. In 2024 the company made an earning of S$82.55 Million, an increase over its 2023 earnings that were of -S$1.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ironwood Pharmaceuticals from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.11 B45.02%
2024 S$82.55 M-106.88%
2023 -S$1.21 Billion-475.59%
2022 S$0.31 B25.8%
2021 S$0.25 B84.32%
2020 S$0.13 B84.69%
2019 S$74.63 M-125.13%
2018 -S$0.3 Billion100.62%
2017 -S$0.15 Billion43.12%
2016 -S$0.11 Billion-42.73%
2015 -S$0.19 Billion-24.76%
2014 -S$0.25 Billion-30.49%
2013 -S$0.35 Billion275.65%
2012 -S$91.96 Million11.56%
2011 -S$82.43 Million9.38%
2010 -S$75.36 Million-15.21%
2009 -S$88.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
S$16.57 B 13,890.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Nektar Therapeutics
NKTR
-S$0.15 Billion-221.61%๐Ÿ‡บ๐Ÿ‡ธ USA